ES8402825A1 - Procedimiento para la preparacion de una imidazolcarboxamida. - Google Patents

Procedimiento para la preparacion de una imidazolcarboxamida.

Info

Publication number
ES8402825A1
ES8402825A1 ES517040A ES517040A ES8402825A1 ES 8402825 A1 ES8402825 A1 ES 8402825A1 ES 517040 A ES517040 A ES 517040A ES 517040 A ES517040 A ES 517040A ES 8402825 A1 ES8402825 A1 ES 8402825A1
Authority
ES
Spain
Prior art keywords
novel
alkyl
hydrogen
imidazolecarboxamide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517040A
Other languages
English (en)
Other versions
ES517040A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of ES8402825A1 publication Critical patent/ES8402825A1/es
Publication of ES517040A0 publication Critical patent/ES517040A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UNA IMIDAZOLCARBOXAMIDA, DE FORMULA GENERAL (I), EN LA QUE Q Y T SON, CADA UNO DE ELLOS INDEPENDIENTEMENTE, UN ATOMO DE OXIGENO; R ES HIDROGENO; R1 ES HIDROGENO, ALQUILO INFERIOR O CF3; R2 ES -NH2, -NH(R5) O -N(R5) (R6); R5 ES ALQUILO INFERIOR, PIRIDINILOFENILO O FENILO SUSTITUIDO; Y R6 ES ALQUILO INFERIOR, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN HACER REACCIONAR UNA AMINOCETONA, DE FORMULA GENERAL (II), EN LA QUE R1 Y R2 TIENEN EL SIGNIFICADO YA MENCIONADO, CON UNA SAL DE CIANATO.DE APLICACIONEN MEDICINA COMO AGENTES ANTIALERGICOS.
ES517040A 1981-11-04 1982-11-02 Procedimiento para la preparacion de una imidazolcarboxamida. Granted ES517040A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31795881A 1981-11-04 1981-11-04

Publications (2)

Publication Number Publication Date
ES8402825A1 true ES8402825A1 (es) 1984-03-01
ES517040A0 ES517040A0 (es) 1984-03-01

Family

ID=23235997

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517040A Granted ES517040A0 (es) 1981-11-04 1982-11-02 Procedimiento para la preparacion de una imidazolcarboxamida.

Country Status (17)

Country Link
EP (1) EP0078546B1 (es)
JP (1) JPS5885868A (es)
KR (1) KR880002709B1 (es)
AT (1) ATE23525T1 (es)
AU (1) AU556124B2 (es)
CA (1) CA1178590A (es)
DE (1) DE3274236D1 (es)
DK (1) DK488382A (es)
ES (1) ES517040A0 (es)
GB (1) GB2110668B (es)
GR (1) GR77374B (es)
IE (1) IE54512B1 (es)
IL (1) IL67132A0 (es)
NO (1) NO156450C (es)
NZ (1) NZ202351A (es)
PH (1) PH21140A (es)
ZA (1) ZA827975B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
US5002961A (en) * 1987-10-19 1991-03-26 Merrell Dow Pharmaceuticals Method for reducing injury with imidazol-2-thionecarboxamides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303199A (en) * 1963-07-15 1967-02-07 Geigy Chem Corp Certain imidazolone derivatives and process for making same
DD140966A1 (de) * 1978-12-28 1980-04-09 Doerthe Creuzburg Mittel zur regulierung des pflanzenwachstums

Also Published As

Publication number Publication date
IE822622L (en) 1983-05-04
EP0078546B1 (en) 1986-11-12
GB2110668A (en) 1983-06-22
ATE23525T1 (de) 1986-11-15
CA1178590A (en) 1984-11-27
NO156450B (no) 1987-06-15
JPH0435467B2 (es) 1992-06-11
AU9011282A (en) 1983-05-12
NO823646L (no) 1983-05-05
GB2110668B (en) 1985-06-19
AU556124B2 (en) 1986-10-23
IL67132A0 (en) 1983-03-31
DE3274236D1 (de) 1987-01-02
JPS5885868A (ja) 1983-05-23
KR880002709B1 (ko) 1988-12-26
IE54512B1 (en) 1989-11-08
EP0078546A1 (en) 1983-05-11
DK488382A (da) 1983-05-05
NZ202351A (en) 1986-02-21
ZA827975B (en) 1983-08-31
NO156450C (no) 1987-09-23
ES517040A0 (es) 1984-03-01
GR77374B (es) 1984-09-11
KR840002360A (ko) 1984-06-25
PH21140A (en) 1987-07-27

Similar Documents

Publication Publication Date Title
ES8703142A1 (es) Proceso para preparar un derivado del bencimidazol.
AU537414B2 (en) Pyroglutamic acid derivatives
FI892787A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
ES2045109T3 (es) 1-fenil-3-naftaleniloxipropanaminas.
MY111814A (en) Watersoluble azole antifungals
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
ES465384A1 (es) Procedimiento para la obtencion de ciclopentan-1-aminas
ES8603711A1 (es) Procedimiento para preparar compuestos benzimidazoles 2-piridilmetil-tio y sulfinil substituidos
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
MY104271A (en) Certain 2-(2'',3'',4''-trisubstituted benzoyl)-1,3- cyclohexanediones
ES2046229T3 (es) Composicion antiulcerosa.
ES8402825A1 (es) Procedimiento para la preparacion de una imidazolcarboxamida.
CA1264753C (en) 2-PYRIDYLCARBOXAMIDES
MY102094A (en) A vinyl or ethynyl substituted aralkyl aryl compound for use as an insecticide/acaricide.
GB8708233D0 (en) Pharmaceutically active compounds
MY101309A (en) Benzoylureas, and their production and use
IL80931A0 (en) Fluorine-containing 1,4-dihydropyridines,their preparation and medicaments containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303